• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION HD CARTRIDGE LINES; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION HD CARTRIDGE LINES; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 101025
Medical Device Problem Codes Fluid/Blood Leak (1250); Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 06/23/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that 15 minutes after starting treatment with a cartridge line, an external blood leak between the arterial patient line and the arterial injection port was observed.It was further reported an alarm was generated.According to the reporter it was ¿a clean cut¿ and ¿the tubing just cut off and the patient started bleeding out".The blood loss was 700-1000 ml.No clinical symptoms were reported; however, ¿extra fluid¿ was administered to the patient prior to leaving.No additional information is available.
 
Additional Manufacturer Narrative
Additional information added to d9, h3, h4, h6 and h10.H10: the device was received for evaluation.Visual inspection with the naked eye showed a disconnection at the transport tube and the arterial red access point.There was no solvent observed at the tip of the transport tube (where it is assembled with the arterial access point), and the arterial access point had no solvent at its port.The reported condition was verified.Seven (7) photographs of the sample were provided for evaluation and showed the connection of the transport tube detached from the arterial red access point.Eight (8) retain samples of the same involved lot number (ma0122333011) were received for evaluation.The samples were visually inspected with the naked eye and leak testing was performed.The retained samples were found within the specifications.The cause of the condition was determined to be a manufacturing issue.A nonconformance has been opened to address this issue.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HD CARTRIDGE LINES
Common Device Name
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - TIJUANA BAJA
blvd pacifico 10014
parque industrial pacifico
tijuana baja california CP 22 643
MX   CP 22643
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key17333452
Report Number8030638-2023-00015
Device Sequence Number6573746
Product Code FJK
UDI-Device Identifier07332414007836
UDI-Public(01)07332414007836
Combination Product (Y/N)N
Initial Reporter StateMT
Initial Reporter CountryUS
PMA/510(K) Number
K070414
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/15/2025
Device Catalogue Number101025
Device Lot NumberMA0122333011
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/23/2023
Supplement Date Received by Manufacturer08/22/2023
Initial Report FDA Received Date07/17/2023
Supplement Report FDA Received Date08/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/12/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-